[99], which involved transplantations of fecal microbiota obtained from depressed patients into a microbiota-depleted antibiotic rat model, the animals developed depressive-like symptoms, which were manifested by behavioral differences such as decreased sucrose intake in the sucrose preference test, a lower number of entries to an open arm in the elevated plus-maze test, and an increase in a plasma kynurenine/tryptophan ratio
So when you stop taking a GLP-1, food once again moves faster through the stomach, leading to weaker signals to stop eating and potentially increasing food intake
Indeed, semaglutide epitomized the global popularity of GLP-1 drugs
Islets were then manually traced and quantified using ImageJ software (NIH)
This mostly modulates GLP-1 homeostasis through the action of a GLP-1 receptor agonist [31]
In recent years, there has been an increasing body of evidence to suggest that GLP-1s are an effective treatment as a weight-loss medication